Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Burroughs Amy L. reported 3 trades in Terns Pharmaceuticals, Inc. shares (Form 4)
Traded May 5, 2026 · Filed May 5, 2026
On May 5, 2026, Burroughs Amy L. (Director, Chief Executive Officer) reported 3 trades in Terns Pharmaceuticals, Inc. shares at US$53.00 for US$8.21M, leaving 0 shares. Filed May 5, 2026 (Form 4).
- Shares
- 154,933 shares
- Price
- US$53.00
- Value
- US$8.21M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Other | 146,614 | US$53.00 | 0 | Direct |
| May 5, 2026 | Common Stock | Other | 8,319 | US$53.00 | 0 | Indirect |
| May 5, 2026 | Common Stock | Disposition | 150,000 | US$53.00 | 0 | Direct |
Source
Related
- Terns Pharmaceuticals, Inc.
- Burroughs Amy L.
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026